Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features

Gulnur Guler, Cigdem Himmetoglu, Rafael E. Jimenez, Susan M. Geyer, Wenle P. Wang, Stefan Costinean, Robert T. Pilarski, Carl Morrison, Dinc Suren, Jianhua Liu, Jingchun Chen, Jyoti Kamal, Charles L. Shapiro, Kay Huebner

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


Landmark studies of the status of DNA damage checkpoints and associated repair functions in preneoplastic and neoplastic cells has focused attention on importance of these pathways in cancer development, and inhibitors of repair pathways are in clinical trials for treatment of triple negative breast cancer. Cancer heterogeneity suggests that specific cancer subtypes will have distinct mechanisms of DNA damage survival, dependent on biological context. In this study, status of DNA damage response (DDR)-associated proteins was examined in breast cancer subtypes in association with clinical features; 479 breast cancers were examined for expression of DDR proteins γH2AX, BRCA1, pChk2, and p53, DNA damage-sensitive tumor suppressors Fhit and Wwox, and Wwox-interacting proteins Ap2α, Ap2γ, ErbB4, and correlations among proteins, tumor subtypes, and clinical features were assessed. In a multivariable model, triple negative cancers showed significantly reduced Fhit and Wwox, increased p53 and Ap2γ protein expression, and were significantly more likely than other subtype tumors to exhibit aberrant expression of two or more DDR-associated proteins. Disease-free survival was associated with subtype, Fhit and membrane ErbB4 expression level and aberrant expression of multiple DDR-associated proteins. These results suggest that definition of specific DNA repair and checkpoint defects in subgroups of triple negative cancer might identify new treatment targets. Expression of Wwox and its interactor, ErbB4, was highly significantly reduced in metastatic tissues vs. matched primary tissues, suggesting that Wwox signal pathway loss contributes to lymph node metastasis, perhaps by allowing survival of tumor cells that have detached from basement membranes, as proposed for the role of Wwox in ovarian cancer spread.

Original languageEnglish (US)
Pages (from-to)421-432
Number of pages12
JournalBreast Cancer Research and Treatment
Issue number2
StatePublished - Sep 2011


  • DNA damage response proteins
  • Fhit
  • Lymph node metastases
  • Tissue microarrays
  • Triple negative breast cancer
  • Wwox

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features'. Together they form a unique fingerprint.

Cite this